[Triamterene in diuretic therapy of cirrhogenic ascites. Modifications of water-saline metabolism induced by its administration alone and in combination with fluprednisolone, methopyrone, mercaptomerine and benzothiazides].
D001201:Ascites / Q000188:drug therapy*; D001581:Benzothiadiazines / Q000627:therapeutic use*; D005477:Fluprednisolone / Q000627:therapeutic use*; D006801:Humans; D008103:Liver Cirrhosis / Q000150:complications; D008297:Male; D008797:Metyrapone / Q000627:therapeutic use*; D009941:Organomercury Compounds / Q000627:therapeutic use*; D014223:Triamterene / Q000627:therapeutic use*; D014882:Water-Electrolyte Balance / Q000187:drug effects
D001581:Benzothiadiazines; D009941:Organomercury Compounds; D005477:Fluprednisolone; D014223:Triamterene; D008797:Metyrapone
Il triamterene nella terapia diuretica delle asciti cirrogene. Modificazioni del metabolismo idro-saline indotte dalla somministrazione singola e dall'associazione con fluprednisolone, metopirone, mercaptomerine e benzotiazidici.